Remove 2021 Remove Financial Market Remove License
article thumbnail

Titagarh Railsystems vs Jupiter Wagons – Future Plans & More

Trade Brains

Particulars/ Financial Year Revenue (Cr.) 2021-22 ₹ 1,467.50 ₹ 1,178.35 2021-22 ₹ -0.68 ₹ 49.65 Particulars/ Financial Year Debt to Equity Titagarh Railsystems Jupiter Wagons 2022-23 0.71 Particulars/ Financial Year Interest Coverage Titagarh Railsystems Jupiter Wagons 2022-23 3.24 crore and Rs. crore and Rs.

Planning 105
article thumbnail

Fundamental Analysis of Ujjivan Small Finance Bank

Trade Brains

It is licensed under the Banking Regulation Act, to carry out small finance bank business. Ujjivan Financial Services is its Parent Company holding an 80 percent stake in the bank. Then we will look at the return generated by the Bank towards its shareholders, before finally reaching a conclusion. These deposits grew by ~40%, from Rs.

Banking 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fundamental Analysis of Bajaj Consumer Care – Financials & More

Trade Brains

The company turned into a subsidiary of Bajaj Resources in 2008, licensing its brand to itself. Bajaj Consumer Care – Financials Revenues, Operating Profit, and Net Profit Growth Financial Year Revenues (Rs In Cr) Operating Profit Margin Net Profits (Rs. 184 FY 2021 921 29.4% FY 2021 29.47 FY 2020 28.28

article thumbnail

Best Dividend Stocks Under Rs 50 To Add To Your Watchlist

Trade Brains

The company has financially outperformed the preceding years with a whooping increase in profit of 13.12% from 40.76% in FY 2021-22 to 46.11% in FY 2022-23. crores during FY 2021-22. Market Cap (Cr) Rs 13,887.9 per share at the end of FY 2021-22. Market Cap (Cr) Rs 43,153.17 Market Cap (Cr) Rs 1,024.28

Banking 97
article thumbnail

Everything you need to know about NSE IPO

Trade Brains

Indian exchanges also have more non-core operating revenues, which is unique to this market. Financial Highlights Of NSE IPO Financial Year Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Revenue (Crores) 3,508 5,625 8,929 11,856 14,780 Net Profit (Crores) 1885 3573 5198 7356 8306 EBITDA(Crores) 2,706 4690.98 crores in 2024.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

Particulars / Fiscal Year 2019 2020 2021 2022 2023 5 Year CAGR Cipla - Revenue ₹16,362.00 ₹17,132.00 ₹19,160.00 ₹21,763.00 ₹22,753.00 Particulars / Fiscal Year 2019 2020 2021 2022 2023 5 Year Avg Cipla - Debt to Equity 0.29 Profitability of Cipla & Dr. Reddy’s grew by 16% and 23% on a 5 Year CAGR. respectively. respectively.

article thumbnail

Minda Corporation Vs Pricol – Financials, Future Plans & More

Trade Brains

The Company also secured a Technology License Agreement (TLA) with LocoNAV to integrate its proprietary telematics technology in products supplied by Minda Corp. Particulars / Fiscal Year 2019 2020 2021 2022 2023 4 Year CAGR Minda Corp - Revenue ₹3,082.00 ₹2,265.20 ₹2,401.10 ₹3,000.10 ₹4,315.90 192 Cr in FY22 to Rs.